What is NDC 72189-370?

72189-370 is the product NDC for Lansoprazole DR, Lansoprazole 30 mg/1 capsule, delayed release, listed with the FDA by Direct_Rx. It has 1 package NDC, shown above in 10- and 11-digit form.

Direct_Rx, NDC labeler code 72189. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lansoprazole DR?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lansoprazole DR NDC 72189-370 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72189-370Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72189-0370Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72189-370-30	7218903703072189037030	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72189-370-30)Marketed from Aug 8, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lansoprazole DR
Generic name (nonproprietary): lansoprazole dr
Active ingredients: Lansoprazole — 30 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Direct_RxNDC labeler code 72189
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205868
Marketing start: Aug 8, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Inhibition Gastric Acid Secretion (Physiologic effect)Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 72189-370_201d8e02-32f5-a292-e063-6294a90af7bdSPL ID 201d8e02-32f5-a292-e063-6294a90af7bdSPL set ID e5bcfc5b-f5a9-3260-e053-2a95a90ab70eRxCUI 311277UNII 0K5C5T2QPG
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472189037030 followed by a unit qualifier and the quantity

Package 72189-0370-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 20, 2024.

Indications (excerpt from the label)

1.1 Treatment of Active Duodenal Ulcer Lansoprazole delayed-release capsules are indicated in adults for short-term treatment (for four weeks ) for healing and symptom relief of active duodenal ulcer [see Clinical Studies ( 14.1]. 1.2 Eradication of H. pylori to Reduce the Risk of Duodenal Ulcer Recurrence Triple Therapy: Lansoprazole /amoxicillin /clarithromycin Lansoprazole delayed-release capsules in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduc…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72189-370

What is NDC 72189-370?: 72189-370 is the product NDC for Lansoprazole DR, Lansoprazole 30 mg/1 capsule, delayed release, listed with the FDA by Direct_Rx. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lansoprazole DR.
What is the active ingredient?: Lansoprazole.
Who is the labeler?: Direct_Rx, NDC labeler code 72189. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lansoprazole DR?: 2 other product NDCs are listed under this name. See all Lansoprazole DR NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lansoprazole DR NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lansoprazole DRlansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0174	80425-0174-01
Lansoprazole DRlansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0148	80425-0148-0180425-0148-02

Other NDCs under ANDA 205868

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205868
Product	Strength	Form · route	Labeler	Product NDC
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	A-S Medication Solutions	50090-6079
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-2274
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-3633
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-5119
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals, Inc.	68788-7742
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Lifestar Pharma LLC.	70756-806
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Lifestar Pharma LLC.	70756-807
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-1425
Lansoprazole DRlansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0174